I am a Pharmacist  

Share

    


In This Section

Home / I Am A Pharmacist

I Am A Pharmacist

Cancer treatment regimens today are so complex that oncology pharmacists and administrators for oncology pharmacy services must take a leadership role as part of the multidisciplinary cancer care team. ACCC understands your pivotal role in delivery of quality, patient-centered care. We've curated content designed to facilitate the important work you do as a pharmacist.

Featured Pharmacist Programs

Oncology Pharmacy Education Network

As oncology engages in value-based reimbursement, new payment models, and precision medicine, oncology pharmacists and pharmacy staff are integral to successful delivery of quality, cost-effective patient care. The ACCC Oncology Pharmacy Education Network (OPEN) offers the knowledge and know-how to navigate the accelerating course of change in oncology—clinically, operationally, fiscally, and programmatically.
Learn More

Perspectives on Step Therapy in Oncology

Explore the implications of potential implementation of step therapy in Medicare Advantage plans.
Learn More

Oncology Drug Database

This is a comprehensive, timely, and authoritative source of information on coding, billing, and reimbursement for oncology drugs, which includes information for both provider administered (“Part B”) and prescribed (“Part D”) drugs commonly used in treating cancer patients in the ambulatory setting, including both therapeutics and supportive care products.
Learn More

Immuno-Oncology Resources

The Oncology Pharmacist's Role in IO Delivery
by Sarah Hudson-DiSalle, PharmD, RPh

Oncology Pharmacist's Role in IO
by Ali Mc Bride

 

From Oncology Issues

  • An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Finalization of the Model and Implications for Clinical Practice in the United States
    Randall A. Oyer, MD, et al.
    In this article, the authors discuss revisions to the Optimal Care Coordination Model following beta testing to develop the final version, rationale for significant revisions, and nationwide dissemination of the Model.
  • Implementing a Transportation Hub: A Holistic Approach to a Systemic Problem
    Rachel Marquez, BS, MPH
    Patients with cancer who face transportation barriers often find themselves at a crossroads: They must either continue to piece together various forms of assistance to try to complete a treatment regimen and protocol or throw in the towel altogether. Instead of reacting to patients’ needs after they fall out of compliance with their specified treatment, we pledged to proactively offer and find transportation assistance that meets all patient needs.
  • Carrie's TOUCH: Supporting Black Women with Breast Cancer
    Maddelynne Parker and Tammie Denyse, M. DIV., MCL
    With disparate breast cancer outcomes, lack of messages of hope, and limited available support for Black women, Rev. Tammie and her late sister were inspired to co-found Carrie’s TOUCH in 2006.
  • Community Oncology Can Close the Gap in Cancer Research
    Amanda Patton, MA
    One of the ways in which community oncology is helping to close gaps in cancer research is through participation in the National Cancer Institute Community Oncology Research Program clinical trials. The Lahey Health Cancer Institute, a part of the Beth Israel Lahey Health System, continues to expand access to clinical trials and, in particular, the NCI National Clinical Trials Network into the community by partnering with affiliated community hospitals.
  • A Nurse Navigator Led Community-Based Cardio-Oncology Clinic
    Rachel Zirkelback, BA, et al.
    Dr. Vijay Rao and Dr. Eric Stephen Rubenstein returned from a Global Cardio-Oncology Society meeting g with the realization that they could do much more to protect patients with cancer from potential cardiac toxicity of chemotherapy. The two shared one goal: to prevent the cancer survivor of today from becoming the heart failure patient of tomorrow.
  • Trending Now in Cancer Care
    Alexandria Howson, PhD
    Rather than fielding its annual Trending Now in Cancer Care survey while cancer programs were experiencing unprecedented challenges due to the extended public health emergency, ACCC chose to facilitate conversations with its members to capture the lived experiences of the most pertinent issues impacting oncology practice and care delivery.
  • Reflections on a Career: A Conversation with ASCO's Dr. Richard Schilsky
    Barbara A. Gabriel, MA
    Oncology Issues sat down with Dr. Schilsky to look back on his career and look forward to future research breakthroughs in this era of COVID-19 and beyond.
  • Compliance: Behavior Health Assessment and Intervention for Oncology Patients
  • Leveraging Technology to Reduce Hospital and Emergency Room Admissions and Identify Patient Comorbidities
    Larry E. Bilbrey, et al.
    It is well documented, even beyond Tennessee Oncology's OCM experience, that patients with cancer generally have some type of hospital-related costs during their disease treatment. Understanding the impact of these real-time alerts and data, Tennessee Oncology formed a Care Transformation Team with the focus of addressing admissions in real time, as well as follow-up care for discharges.
  • Views: Developing Effective Cancer Program Leadership
    Barbara Schmidtman, PhD, MAOL, CNMT
    As the senior director of cancer services at Spectrum Health Lakeland in St. Joseph, Mich., I led a breakout session at the 37th [Virtual] ACCC National Oncology Conference in September 2020, where I shared tips for effective and positive leadership in oncology. The first step to becoming an effective leader is to understand the type of leader you are—even if you hold an informal leadership position.
  • Issues: Recent Trends in White Bagging and Brown Bagging
    Kristin Ferguson, DNP, RN, OCN
    Over the last several months, ACCC members have experienced a rising trend of payer-mandated white and brown bagging. ACCC will continue to monitor and update members about issues related to white and brown bagging.
  • An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Results from Beta Model Testing
    Matthew P. Smeltzer, PhD, MSTAT, et al.
    In 2016, the Association of Community Cancer Centers (ACCC) initiated a three-year multiphase project to develop an Optimal Care Coordination Model (OCCM) for Medicaid patients with lung cancer that would help assess and strengthen care delivery systems by facilitating and expanding access to multidisciplinary coordinated care.
  • Driving Oncology Forward
    Krista Nelson, MSW, LCSW, OSW-C, FAOSW
    This next year, as we emerge out of COVID-19’s shadow and into a landscape that has been forever altered by the worldwide pandemic, it is important that we reflect on what we witnessed this past year—not only the suffering but the “wins.”
  • How Oncology Can Help Improve Vaccination Rates
    Sibel Blau, MD
    Oncologists may not be on the frontline taking care of patients with COVID-19 in intensive care units or emergency departments, but we do have the chance to advocate for vaccination to win the race against this deadly virus.
  • A Pharmacist-Managed Oral Chemotherapy Program
    The shift from infused to oral agents has implications for patients and cancer programs. This 2011 ACCC Innovator Award winning program explains its pharmacist-managed approach.
  • ACCESS: The First Step Toward Analyzing Precision Medicine Data
    Jonathan Trent, MD, PhD
    Before we can precisely characterize a disease, prescribe targeted medicine, and track therapy progress, we need to find a better way to order tests, store results, and share information. Read how Sylvester Cancer Center in Miami did just that by integrating precision medicine data into its electronic health record (EHR).
  • The Role of the Oral Oncology Nurse Navigator
    Mary K. Anderson, BSN, RN, OCN; Michael J. Reff, RPH, MBA; Rebecca S. McMahon, MHA, BSN, RN, OCN; and Deborah R. Walters, RN, OCN
    While oncology programs and practices must take into account numerous considerations when ramping up their oral chemotherapy services, this article focuses on one unique and very important role to facilitate this transition: the oral oncology nurse navigator.
  • Delivering Pharmacogenetic Testing in the Community Setting
    Mark Wagner, PharmD; Jennifer Eichmeyer, MS, CGC; Paul G. Montgomery, MD; Jessica Monitz, PharmD; Jesslie Modlin, PharmD; and Natalie Perry, BA
    In November 2014, St. Luke’s Mountain States Tumor Institute (MSTI), Boise, Idaho, initiated a pilot program to determine the feasibility of a pharmacogenetic testing program in a community cancer program.

ACCCBuzz Blog Posts

FROM THE ACCCBUZZ BLOG

  • Discussions that Matter: A Look at the Current Drug Shortage
    July 10, 2023
    In the face of an unprecedented drug shortage, Hematology/Oncology Pharmacy Association (HOPA) partnered with the Association of Community Cancer Centers (ACCC) and Association of VA Hematology/Oncology (AVAHO) to lead a virtual round table aimed at developing practical strategies healthcare organizations around the country can adopt.
  • The Psychosocial and Financial Aspects of Treating Myelofibrosis
    April 11, 2023
    ACCCBuzz spoke with Julie Huynh-Lu, PA-C—physician assistant in the Department of Leukemia at the University of Texas MD Anderson Cancer Center—to learn more about enhancing the care for patients with myelofibrosis by assessing and addressing their psychosocial and financial health.
  • An Update on Healthcare Legislation at the State Level
    By Christian G. Downs, MHA, JD
    March 22, 2023
    If you are looking for legislative action, look no further than your state's legislatures. Most—if not all—states have had issues relating to oncology care and healthcare in general come up during their 2023 sessions.
  • #AMCCBS: Clinical & Operational Updates in Oncology
    March 09, 2023
    Before opening the ACCC 49th Annual Meeting & Cancer Center Business Summit to its membership, ACCC held two pre-conference events on Wednesday, March 8. Learn more about what was discussed among invited speakers during these events.
  • ACCC Announces its 2023 Advocacy Agenda
    March 07, 2023
    For 2023, ACCC members have identified four core areas of focus (e.g., reimbursement, utilization management, provider-patient choice), among a larger set of issues and concerns, that the association will be supporting this year.
  • Triplet vs. Quadruplet Therapy: Choosing the Right Multiple Myeloma Treatment
    November 23, 2022
    ACCCBuzz spoke with Dr. Jessica Unzaga at Baptist Health’s Miami Cancer Institute, to help consider the use of triplet vs. quadruplet regimens in the treatment of multiple myeloma.